科研动态PubMed 摘要

维生素D-VDR信号在甲状腺疾病中的作用:分子机制、自身免疫、遗传易感性、实验证据与治疗转化的系统综述。

PubMed 学科轮询 · 2026-10-20

完整摘要 · 中文译文

维生素D-维生素D受体(VDR)信号传导的作用不仅限于钙磷稳态,还调控免疫耐受、炎症、细胞分化、氧化应激和内分泌生理。本系统综述评估了维生素D-VDR信号传导与甲状腺疾病之间的关系,包括甲状腺功能减退症、甲状腺功能亢进症、桥本甲状腺炎、Graves病、甲状腺自身免疫、遗传易感性、实验机制和治疗意义。本研究按照PRISMA 2020声明实施和报告。检索了PubMed/MEDLINE和Scopus中2005年1月至2026年6月发表的研究,并辅以对相关研究和综述的前向与后向引文筛选。符合条件的证据包括人体观察性研究和干预性研究、遗传学研究,以及涉及维生素D状态、维生素D暴露或补充、VDR变异、维生素D代谢或维生素D-VDR机制与甲状腺功能、甲状腺疾病、甲状腺自身抗体或相关生物学结局之间关系的相关动物和体外研究。共识别出13,623条记录,其中11,730条唯一记录接受了标题和摘要筛选,449篇报告在全文本阶段接受评估,118项原始研究纳入最终综合。由于人群、研究设计、维生素D暴露、结局、遗传背景和实验模型存在显著异质性,研究结果以叙述性方式综合,而非通过定量荟萃分析。 较低的循环25-羟基维生素D[25(OH)D]浓度常与甲状腺疾病相关,尤其是自身免疫表型,并且在桥本甲状腺炎中与甲状腺过氧化物酶抗体和甲状腺球蛋白抗体升高相关。干预性证据提示,补充维生素D可能降低部分自身免疫性甲状腺疾病患者的甲状腺过氧化物酶抗体(TPOAb)和甲状腺球蛋白抗体(TgAb)浓度。然而,这些实验室指标变化代表免疫学替代终点,不应被解释为甲状腺功能恢复、阻止进展为显性甲状腺功能减退症、减少对甲状腺激素替代治疗的依赖或持续临床缓解的证据。随机证据并未确立补充维生素D对 incident hypothyroidism 具有普遍预防作用。VDR基因多态性,包括FokI/rs2228570、rs1544410、rs731236和rs7975232,与甲状腺自身免疫之间的关联在不同人群中并不一致。实验证据涉及免疫调节、Th17/Treg平衡、炎症信号传导、维生素D代谢以及钙磷稳态。现有证据受到显著临床、方法学和生物学异质性、频繁依赖观察性研究、人群特异性遗传学发现以及实验模型与人类甲状腺生理差异的限制。总体而言,维生素D-VDR信号传导代表一种生物学上合理的甲状腺疾病修饰因素,但当前证据尚未确立普遍因果关系或治疗效 疗效。

完整摘要 · 英文原文

Vitamin D-Vitamin D receptor (VDR) signaling extends beyond calcium-phosphate homeostasis and regulates immune tolerance, inflammation, cellular differentiation, oxidative stress, and endocrine physiology. This systematic review evaluated the relationship between vitamin D-VDR signaling and thyroid disorders, including hypothyroidism, hyperthyroidism, Hashimoto's thyroiditis, Graves' disease, thyroid autoimmunity, genetic susceptibility, experimental mechanisms, and therapeutic implications. This study was conducted and reported in accordance with the PRISMA 2020 statement. PubMed/MEDLINE and Scopus were searched for studies published from January 2005 through June 2026, supplemented by backward and forward citation screening of relevant studies and reviews. Eligible evidence included human observational and interventional studies, genetic investigations, and relevant animal and in vitro studies addressing vitamin D status, vitamin D exposure or supplementation, VDR variation, vitamin D metabolism, or vitamin D-VDR mechanisms in relation to thyroid function, thyroid disease, thyroid autoantibodies, or related biological outcomes. A total of 13,623 records were identified, of which 11,730 unique records underwent title and abstract screening, 449 reports were assessed at the full-text stage, and 118 primary studies were included in the final synthesis. Because of substantial heterogeneity in populations, study designs, vitamin D exposures, outcomes, genetic backgrounds, and experimental models, findings were synthesized narratively rather than by quantitative meta-analysis. Lower circulating 25-hydroxyvitamin D [25(OH)D] concentrations were frequently associated with thyroid disease, particularly autoimmune phenotypes, and increased thyroid peroxidase and thyroglobulin antibodies in Hashimoto's thyroiditis. Interventional evidence suggests that vitamin D supplementation may reduce thyroid peroxidase antibody (TPOAb) and thyroglobulin antibody (TgAb) concentrations in some patients with autoimmune thyroid disease. However, these laboratory changes represent immunological surrogate outcomes and should not be interpreted as evidence of restored thyroid function, prevention of progression to overt hypothyroidism, reduced dependence on thyroid hormone replacement, or sustained clinical remission. Randomized evidence does not establish a general preventive effect of vitamin D supplementation on incident hypothyroidism. Associations between VDR polymorphisms, including FokI/rs2228570, rs1544410, rs731236, and rs7975232, and thyroid autoimmunity were inconsistent across populations. Experimental evidence implicates immune regulation, Th17/Treg balance, inflammatory signaling, vitamin D metabolism, and calcium-phosphate homeostasis. The evidence was limited by substantial clinical, methodological, and biological heterogeneity, frequent reliance on observational studies, population-specific genetic findings, and differences between experimental models and human thyroid physiology. Overall, vitamin D-VDR signaling represents a biologically plausible modifier of thyroid disease, but current evidence does not establish universal causality or therapeutic efficacy.

English
Vitamin D-VDR Signaling Across Thyroid Disorders: A Systematic Review of Molecular Mechanisms, Autoimmunity, Genetic Susceptibility, Experimental Evidence and Therapeutic Translation.
内容仅供参考,不构成诊疗建议,不能替代执业医师的诊断。

← 返回元界